Applications from the field of Pharma & Biopharma from Bruker - page 1
Open paper Analysis of Potential Genotoxic Impurities in the Drug Developement Process using GC-MS/MS
GCMS
Analysis of Potential Genotoxic Impurities in the Drug Developement Process using GC-MS/MS
GC/MSD, GC/MS/MS, GC/QQQ
Instrumentation
GC/MSD, GC/MS/MS, GC/QQQ
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper Determination of Class I USP Residual Solvents and TICs in Dietary Supplements and Pharmaceutical Products by GC/MS
GCMS
Determination of Class I USP Residual Solvents and TICs in Dietary Supplements and Pharmaceutical Products by GC/MS
GC/MSD, HeadSpace, GC/SQ
Instrumentation
GC/MSD, HeadSpace, GC/SQ
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper The Analysis of Residual Solvents By Headspace Sampling and GC According to USP <467>
GCMS
The Analysis of Residual Solvents By Headspace Sampling and GC According to USP <467>
GC, HeadSpace
Instrumentation
GC, HeadSpace
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper Development of timsMRMS: A Gated-TIMS FT-ICR MS instrument to decipher isomeric content of complex organic mixtures
LCMS
Development of timsMRMS: A Gated-TIMS FT-ICR MS instrument to decipher isomeric content of complex organic mixtures
LC/MS, LC/MS/MS, Ion Mobility, LC/Ultra-HRMS, MALDI, MS Imaging
Instrumentation
LC/MS, LC/MS/MS, Ion Mobility, LC/Ultra-HRMS, MALDI, MS Imaging
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper Rapid Quantification of Clinically Relevant Compound Classes by Chromatography-Free DART-MS/MS
LCMS
Rapid Quantification of Clinically Relevant Compound Classes by Chromatography-Free DART-MS/MS
LC/MS, LC/MS/MS, DART, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, DART, LC/QQQ
Manufacturer
Bruker
Industries
Clinical Research, Pharma & Biopharma
Open paper MSⁿ Characterization of Chemical Modifications in Pharmaceutical Protein Byproducts Using the timsOmni Platform
LCMS
MSⁿ Characterization of Chemical Modifications in Pharmaceutical Protein Byproducts Using the timsOmni Platform
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Manufacturer
Bruker
Industries
Pharma & Biopharma, Proteomics
Open paper Top-down sequencing of bispecific antibodies by electron capture dissociation on a timsOmni platform
LCMS
Top-down sequencing of bispecific antibodies by electron capture dissociation on a timsOmni platform
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper Improving de novo sequencing methods and post translational modification screening tools for the analysis of complex protein mass spectra
LCMS
Improving de novo sequencing methods and post translational modification screening tools for the analysis of complex protein mass spectra
Software
Instrumentation
Software
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper Top‐Down Mapping of Protein Modifications by Multimodal MSⁿ on the New timsOmni Platform
LCMS
Top‐Down Mapping of Protein Modifications by Multimodal MSⁿ on the New timsOmni Platform
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility, Software
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility, Software
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper Applying cDDA-eXd on a timsOmni to the analysis of the Fab regions of antibodies originating from human serum
LCMS
Applying cDDA-eXd on a timsOmni to the analysis of the Fab regions of antibodies originating from human serum
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Manufacturer
Bruker
Industries
Pharma & Biopharma
